One the comments I saw over at the other board suggested that the incentive to get all four indications through the Phase II trials as soon as possible was based upon the thought that Leo and Dr. Menon may be looking to sell the entire company. I had not thought of that recently, but it does make me think. Why push to get all four trials completed right now? That is a lot to manage for anyone, let alone a company of this size. I would have no problem with an outright sale of the company if it was for a reasonable amount that also benefitted shareholders. They are not getting any younger.....so who knows?